Catalyst Wire Dossier Catalyst Wire Dossier

MEDI-559

· MedImmune LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MEDI-559, covering 2016-07-20 to 2016-07-20. Get the full timeline:

Most recent: Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate Safety of MEDI-559 in Healthy 1 to <24 Month-Old Children [Phase 1, Phase 2]

See pricing